These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 19206007)

  • 1. Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease?
    Muszynska-Roslan K; Konstantynowicz J; Panasiuk A; Krawczuk-Rybak M
    Pediatr Hematol Oncol; 2009 Jan; 26(1):36-47. PubMed ID: 19206007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
    van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone mineral density in children before and after completion of cancer treatment].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M; Kaczmarski M; Piotrowska-Jastrzebska J
    Pol Merkur Lekarski; 2004 Jul; 17(97):37-42. PubMed ID: 15559608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density in long-term survivors of childhood cancer.
    Hesseling PB; Hough SF; Nel ED; van Riet FA; Beneke T; Wessels G
    Int J Cancer Suppl; 1998; 11():44-7. PubMed ID: 9876477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.
    van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
    J Pediatr; 2002 Aug; 141(2):204-10. PubMed ID: 12183715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal morbidity in childhood acute lymphoblastic leukemia.
    Mandel K; Atkinson S; Barr RD; Pencharz P
    J Clin Oncol; 2004 Apr; 22(7):1215-21. PubMed ID: 15051768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body composition and bone mass in survivors of childhood cancer.
    Muszynska-Roslan K; Konstantynowicz J; Krawczuk-Rybak M; Protas P
    Pediatr Blood Cancer; 2007 Feb; 48(2):200-4. PubMed ID: 16602116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Little evidence of low bone mass in acute lymphoblastic leukemia survivors.
    Muszynska-Roslan K; Panasiuk A; Latoch E; Krawczuk-Rybak M; Konstantynowicz J
    J Clin Densitom; 2012; 15(1):108-15. PubMed ID: 21880524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
    Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
    Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of bone mineral density at different phases of therapy of childhood all.
    Maniadaki I; Stiakaki E; Germanakis I; Kalmanti M
    Pediatr Hematol Oncol; 2006; 23(1):11-8. PubMed ID: 16326407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density in long-term survivors of childhood cancer.
    Arikoski P; Voutilainen R; Kröger H
    J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():343-53. PubMed ID: 12729414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mass and body composition after cessation of therapy for childhood cancer.
    Nysom K; Mølgaard C; Holm K; Hertz H; Michaelsen KF
    Int J Cancer Suppl; 1998; 11():40-3. PubMed ID: 9876476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral status after treatment of malignant lymphoma in childhood and adolescence.
    Sala A; Talsma D; Webber C; Posgate S; Atkinson S; Barr R
    Eur J Cancer Care (Engl); 2007 Jul; 16(4):373-9. PubMed ID: 17587363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density decrements and children diagnosed with cancer.
    Pagano-Therrien J; Santacroce SJ
    J Pediatr Oncol Nurs; 2005; 22(6):328-38. PubMed ID: 16216895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total body bone measurements: a cross-sectional study in children with acute lymphoblastic leukemia during and following completion of therapy.
    Kelly KM; Thornton JC; Hughes D; Osunkwo I; Weiner M; Wang J; Horlick M
    Pediatr Blood Cancer; 2009 Jan; 52(1):33-8. PubMed ID: 18816694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of bone metabolism in children with acute lymphoblastic leukemia after induction chemotherapy treatment.
    Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Koliouskas D; Papastergiou C; Tsituridis I
    Pediatr Hematol Oncol; 2005 Jun; 22(4):285-9. PubMed ID: 16020115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.
    Gunes AM; Can E; Saglam H; Ilçöl YO; Baytan B
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood.
    Odame I; Duckworth J; Talsma D; Beaumont L; Furlong W; Webber C; Barr R
    Pediatr Blood Cancer; 2006 Mar; 46(3):357-62. PubMed ID: 16035080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.